×

CellRapeutics™ CD56+ NK Cells from Systemic Lupus Erythematosus Donor (XS-0426-XU300)

Online Inquiry  Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product features high-purity CD56+ NK cells derived from Systemic Lupus Erythematosus donors. These cells typically reflect the systemic interferon-alpha signature and often exhibit numerical or functional deficiencies common in lupus pathogenesis. This product is prioritized for researchers exploring the failure of NK cells to clear apoptotic debris and their contribution to the loss of B-cell tolerance through aberrant cytokine signaling.

Specific Inquiry

  • Size:
  Add to Cart

Donor Information

  • Product Name
  • CellRapeutics™ CD56+ NK Cells from Systemic Lupus Erythematosus Donor
  • Cat. No.
  • XS-0426-XU300
  • Donor Age
  • Young Adult
  • Donor Health
  • NK cells reflect a state of profound systemic immune dysregulation. They are characterized by impaired cytotoxic efficiency but enhanced interferon-mediated signaling signatures, reflecting the chronic Type I IFN environment of SLE.
  • Ethnicity
  • Primarily African American, Hispanic, and Asian backgrounds.
  • Anticoagulant
  • Acid Citrate Dextrose, prioritized to prevent complement activation and preserve NK cell subset distribution from SLE-associated lymphopenia samples.
  • Additional Donor Information
  • Each lot features CD56+ NK cells from donors with SLE. Profiles include SLEDAI scores and history of immunosuppressants, facilitating research into NK cell deficiency and interferon-gamma production in lupus.
  • Clinical Profile
  • ANA and anti-dsDNA titers, SLEDAI score, organ involvement, and current immunosuppressive regimen.

Additional Information

  • Medication History
  • Available upon request. Records of corticosteroids, antimalarials, and biologics that impact the type I interferon environment and NK cell function.
  • Formulation
  • Cryopreserved in specialized freezing medium
  • Cell Purity
  • >90%
  • Cell Viability
  • >90%
  • Mycoplasma Testing
  • Negative
  • Sterility Testing
  • Negative
  • Genetic Stability Testing
  • The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.
  • Application
  • Drug Discovery, Immuno-oncology Research
  • Research Use Only
  • RUO
  • Quality Control
  • Each product batch undergoes rigorous testing for purity, viability, and microbial contamination.
  • Storage
  • Maintain long-term storage in liquid nitrogen vapor phase (below -150°C), avoid temperature fluctuations above -135°C to preserve NK cell lytic activity.
  • Shiping
  • Dry Ice
  • Handling Notes
  • Perform rapid thawing at 37°C and implement slow, dropwise dilution with pre-warmed media to minimize osmotic stress and ensure optimal cell recovery.
  • Warnings
  • Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.
  • Size
  • 5E6 cells/vial, 1E7 cells/vial
  • Keywords
  • CellRapeutics™ CD56+ NK Cells from Systemic Lupus Erythematosus Donor, CD56+ NK Cells, Systemic Lupus Erythematosus

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ CD56+ NK Cells from Systemic Lupus Erythematosus Donor (XS-0426-XU300). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.